Qube Research & Technologies (QRT)
DNTH icon

Qube Research & Technologies (QRT)’s Dianthus Therapeutics DNTH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Buy
196,924
+166,570
+549% +$14.5M 0.02% 934
2026
Q1 		$2.55M Buy
30,354
+20,060
+195% +$1.16M ﹤0.01% 2033
2025
Q4 		$424K Buy
+10,294
New +$399K ﹤0.01% 2849
2024
Q4 		– Sell
-7,753
Closed -$212K – 3537
2024
Q3 		$212K Sell
7,753
-3,452
-31% -$96.2K ﹤0.01% 2567
2024
Q2 		$290K Sell
11,205
-56,641
-83% -$1.36M ﹤0.01% 2318
2024
Q1 		$2.04M Buy
67,846
+67,044
+8,360% +$1.46M ﹤0.01% 1747
2023
Q4 		$8.34K Buy
802
+799
+26,633% +$8.83K ﹤0.01% 3632
2023
Q3 		$41 Buy
+3
New +$38 ﹤0.01% 3832
2022
Q4 		– Sell
-1,276
Closed -$29K – 2572
2022
Q3 		$29K Sell
1,276
-129
-9% -$3.53K ﹤0.01% 2242
2022
Q2 		$27K Buy
+1,405
New +$34.7K ﹤0.01% 2222
2021
Q3 		– Sell
-818
Closed -$128K – 2330
2021
Q2 		$128K Buy
+818
New +$150K ﹤0.01% 1896

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DNTH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Dianthus Therapeutics (DNTH) stake by 549% in Q2 2026, buying an estimated $14.5M and bringing the position to 196,924 shares worth $19.2M. The position accounts for 0.02% of the portfolio, ranked #934.

Qube Research & Technologies (QRT) first reported a position in DNTH in Q2 2021 and has held it in 11 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 196,924 shares of Dianthus Therapeutics worth $19.2M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 166,570 Dianthus Therapeutics shares in Q2 2026, an estimated $14.5M.
  • Dianthus Therapeutics made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #934 holding.
  • Qube Research & Technologies (QRT) first reported a position in Dianthus Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.